We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 9,266 results
  1. Rational use of inhaled corticosteroids for the treatment of COPD

    Inhaled corticosteroids (ICS) are the mainstay of treatment for asthma, but their role in chronic obstructive pulmonary disease (COPD) is debated....

    Jennifer K. Quint, Amnon Ariel, Peter J. Barnes in npj Primary Care Respiratory Medicine
    Article Open access 24 July 2023
  2. Effect of fracture risk in inhaled corticosteroids in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis

    Background

    The fracture risk of patients with chronic obstructive pulmonary disease (COPD) treated with inhaled corticosteroids is controversial. And...

    Shisheng Peng, Cong Tan, ... Ruiying Wang in BMC Pulmonary Medicine
    Article Open access 17 August 2023
  3. Prescribing practices of inhaled corticosteroids for premature infants in the neonatal intensive care unit

    Objective

    Despite limited safety and efficacy data, inhaled corticosteroids (ICS) are prescribed to premature infants in the neonatal intensive care...

    Monica Tang, Anna Ibrahim, ... Jason E. Lang in Journal of Perinatology
    Article Open access 31 January 2024
  4. Inhaled corticosteroids do not affect the antibody titer against the SARS-CoV-2 spike protein in BNT162b2 mRNA vaccinated patients

    Objectives

    Oral corticosteroids reduce the antibody titer of the BNT162b2 mRNA vaccine against SARS-CoV-2. To date, the effect of inhaled...

    Takeo Nakajima, Tatsuya Nagano, ... Kazuyuki Kobayashi in Allergy, Asthma & Clinical Immunology
    Article Open access 25 August 2022
  5. Use of thiols and implications for the use of inhaled corticosteroids in the presence of oxidative stress in COPD

    Background

    Oxidative stress and persistent airway inflammation are thought to be important contributors to the development of chronic obstructive...

    Mario Cazzola, Clive P. Page, ... Maria Gabriella Matera in Respiratory Research
    Article Open access 31 July 2023
  6. Cough Response to High-Dose Inhaled Corticosteroids in Patients with Chronic Cough and Fractional Exhaled Nitric Oxide Levels ≥ 25 ppb: A Prospective Study

    This study aimed to investigate the effects of high-dose inhaled corticosteroids (ICS) on chronic cough patients with elevated fractional exhaled...

    Ji-Ho Lee, Sung-Yoon Kang, ... Woo-Jung Song in Lung
    Article 11 May 2024
  7. Effect of Long-term Inhaled Corticosteroids on the Hypothalamic-Pituitary-Adrenal Axis in Children with Asthma

    Objectives

    To assess the effect of the long-term use of inhaled corticosteroids (ICS) on the hypothalamic-pituitary-adrenal (HPA) axis.

    ...
    Lekshmi Sambhu Hema, Prawin Kumar, ... Kuldeep Singh in Indian Journal of Pediatrics
    Article 07 July 2023
  8. Inhaled Corticosteroids in Adults with Non-cystic Fibrosis Bronchiectasis: From Bench to Bedside. A Narrative Review

    Due to their potent anti-inflammatory capacity (particularly in predominantly eosinophilic inflammation) and immunosuppressive properties, inhaled...

    Miguel Ángel Martínez-García, Grace Oscullo, ... Mario Cazzola in Drugs
    Article Open access 01 September 2022
  9. Biomarker-guided withdrawal of inhaled corticosteroids in asthma patients with a non-T2 inflammatory phenotype – a randomized controlled trial study protocol

    Background

    Non-T2 asthma is characterized by the absence of elevated type 2 inflammatory biomarkers such as blood-eosinophils, total and...

    Christiane Hammershaimb Mosbech, Nina Skavlan Godtfredsen, ... Christian Grabow Westergaard in BMC Pulmonary Medicine
    Article Open access 04 October 2023
  10. Association of GAB1 gene with asthma susceptibility and the efficacy of inhaled corticosteroids in children

    Asthma is a polygenic disease that may onset during childhood. Inhaled corticosteroids (ICS) are the main therapy in asthma, although their efficacy...

    Yuxuan Zhang, Jun Liu, ... Bing Wei in BMC Pulmonary Medicine
    Article Open access 06 December 2023
  11. Quantitative comparison of different inhaled corticosteroids in the treatment of asthma in children

    Background

    The GINA recommends inhaled corticosteroids (ICSs) for the treatment of steps 2–3 of childhood asthma. However, the difference in efficacy...

    Haoxiang Zhu, Hongxia Liu, ... Lu** Li in Pediatric Research
    Article 11 May 2022
  12. Inhaled corticosteroids, COPD, and the incidence of lung cancer: a systematic review and dose response meta-analysis

    Background

    There has been debate on whether inhaled corticosteroids (ICS) reduce the incidence of lung cancer amongst patients with Chronic...

    Tyler Pitre, Michel Kiflen, ... Juan P. de Torres in BMC Pulmonary Medicine
    Article Open access 17 July 2022
  13. Several Nocardia abcessus bronchiolitis in a patient treated with inhaled corticosteroids: a case report

    Nocardiosis is a disease that mainly affects immunocompromised patients. Inhaled corticosteroids (ICS) are standard of care for asthma. This...

    Estelle Cascarano, Murielle Frappa, ... Hubert Gheerbrant in Allergy, Asthma & Clinical Immunology
    Article Open access 03 April 2023
  14. Pharmacological Basis of Differences in Dose Response, Dose Equivalence, and Duration of Action of Inhaled Corticosteroids

    Introduction

    Asthma treatment guidelines classify inhaled corticosteroid (ICS) regimens as low, medium, or high dose. However, efficacy and safety are...

    Peter T. Daley-Yates, Bhumika Aggarwal, Maximilian Plank in Advances in Therapy
    Article Open access 27 March 2024
  15. Probability of successful inhaled corticosteroids cessation in preschool wheezers: a predictive score

    Nearly all asthma predictive tools estimate the future risk of asthma development. However, there is no tool to predict the probability of successful...

    Kantisa Sirianansopa, Kanokpan Ruangnapa, ... Wanaporn Anuntaseree in European Journal of Pediatrics
    Article 27 October 2022
  16. A descriptive cohort study of withdrawal from inhaled corticosteroids in COPD patients

    Inhaled corticosteroid (ICS) therapy is widely prescribed without a history of exacerbations and consensus guidelines suggest withdrawal of ICS in...

    Smit Patel, Scott Dickinson, ... James D. Chalmers in npj Primary Care Respiratory Medicine
    Article Open access 20 July 2022
  17. Intraclass comparison of inhaled corticosteroids for the risk of pneumonia in chronic obstructive pulmonary airway disorder: a network meta-analysis and meta-regression

    Background

    Inhalational corticosteroids (ICS) were observed to increase the pneumonia risk in chronic obstructive pulmonary airway disorder (COPD)....

    Kannan Sridharan, Gowri Sivaramakrishnan in International Journal of Clinical Pharmacy
    Article 25 April 2024
  18. Up-regulation of ACE2, the SARS-CoV-2 receptor, in asthmatics on maintenance inhaled corticosteroids

    Background

    The first step in SARS-CoV-2 infection is binding of the virus to angiotensin converting enzyme 2 (ACE2) on the airway epithelium. Asthma...

    Sarah L. O’Beirne, Jacqueline Salit, ... Yael Strulovici-Barel in Respiratory Research
    Article Open access 07 July 2021
Did you find what you were looking for? Share feedback.